John B. Rhodes serves as Executive at Tonix Pharmaceuticals Holding Corp., where they oversee executive responsibilities. Since joining the company, John B. Rhodes has executed 9 insider transactions totaling $120.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 1, 2018 involved purchasing 7,500 shares valued at $25.0K.
John B. Rhodes currently holds 23,470 shares of Tonix Pharmaceuticals Holding Corp. (TNXP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John B. Rhodes has been a net buyer of TNXP stock. They have purchased $120.0K and sold $0 worth of shares.
John B. Rhodes's most recent insider trade was on Jun 1, 2018, when they purchased 7,500 shares at $3.33 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 9, 2017 | TNXP | $0 | Option Exercise | 1,125 | $N/A | Discretionary |
| Oct 31, 2016 | TNXP | $0 | Purchase | 25,000 | $N/A | Discretionary |
| Jun 21, 2016 | TNXP | $50.0K | Purchase | 25,000 | $2.00 | Discretionary |
| Feb 25, 2016 | TNXP | $0 | Option Exercise | 600 | $N/A | Discretionary |
| Jul 17, 2015 | TNXP | $45.0K | Purchase | 6,000 | $7.50 | Discretionary |
| Aug 14, 2013 | TNXP | $0 | Purchase | 11,765 | $N/A | Discretionary |
| Apr 26, 2013 | TNXP | $66.7K | Conversion | 166,667 | $0.40 | Discretionary |